ANDA 89893, held by Quad Pharms. Trifluoperazine Hydrochloride.
As of Nov 15, 2026, ANDA 89893 (Trifluoperazine Hcl), held by Quad Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Trifluoperazine HclEQ 2MG BASE/ML ยท injectable; injection | Trifluoperazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
